Day: April 21, 2020

EEZY OYJ  —  YHTIÖTIEDOTE  —  21.4.2020 KLO 15.05Eezy Oyj:n hallituksen järjestäytyminenEezy Oyj:n hallituksen järjestäytymiskokous pidettiin tänään 21.4.2020. Hallitus valitsi puheenjohtajakseen Tapio Pajuharjun.Hallituksen tarkastusvaliokunnan puheenjohtajaksi valittiin Liisa Harjula ja jäseniksi Jarno Suominen ja Kati Hagros.Lisätietoja:Hannu Nymantalousjohtajahannu.nyman@eezy.fipuh. +358 (0)50 306 9913Hyväksytty neuvonantaja:Danske Bank A/S, Suomen sivuliike, puh. +358 (0)10 546 7934

Internationally renowned ophthalmologist, Gerd Auffarth, MD, ranked as one of the “100 most influential personalities in ophthalmology worldwide” in the 2020 Power List published by The Ophthalmologist magazineJulian Gangolli, former President of the North American Pharmaceutical division of Allergan, Inc., brings distinguished track record of successfully overseeing product commercialization launchesCRANBURY, N.J., April 21, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it has bolstered its Board of Directors with the appointments of Prof. Dr. Gerd Auffarth and Mr. Julian Gangolli.“We are incredibly pleased to add...

REDWOOD CITY, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell related diseases, today announced the acceptance of four oral and three poster presentations at the upcoming Digestive Disease Week (DDW) Annual Meeting.The presentations will take place during the DDW Annual Meeting being held virtually from May 2 to 5, 2020. Access to all accepted abstracts, ePosters and ePapers will be available starting May 2 from the DDW ePosters and ePapers website. In addition, abstracts will publish in the May online supplement to Gastroenterology.Oral Presentations:Poster Presentations:Following the presentations, the posters and slides will be available on the Allakos website.About AllakosAllakos is a clinical...

OXFORD, Mass., April 21, 2020 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) will release its first quarter 2020 financial results before the market opens on Tuesday, May 5, 2020. The company will hold a conference call to review these results at 10:00 AM ET that same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the company’s website at investor.ipgphotonics.com.About IPG Photonics CorporationIPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The company’s mission is to make its fiber laser technology the tool of choice in mass production. IPG accomplishes this...

HOUSTON, April 21, 2020 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its third quarter fiscal year 2020 financial results at 10 a.m. (Eastern) on Tuesday, May 5, 2020.All interested parties are invited to listen online at investors.sysco.com. A replay of the webcast will be available online at investors.sysco.com shortly after the live webcast is completed. Prior to the conference call and webcast, the company will also issue a news release and post a slide presentation online at investors.sysco.com.For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations portion of its website as the primary channel for publishing key information to its investors, some of which may contain material and previously non-public information.About...

GREENSBORO, N.C., April 21, 2020 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, will host a conference call to review fiscal 2020 fourth quarter financial results on Thursday, May 7, 2020, at 5:00 p.m. (ET). The conference call will be webcast live on the Company’s website at the following URL: http://www.qorvo.com (under “Investors”).A telephone playback of the conference call will be available approximately two hours after the call’s completion and can be accessed by dialing 719-457-0820 and using the passcode 6708971. The playback will be available through the close of business May 14, 2020.Qorvo will distribute fiscal 2020 fourth quarter financial results at approximately 4:00 p.m. (ET) on Thursday, May 7, 2020.About QorvoQorvo (Nasdaq: QRVO) makes a better...

MOORESTOWN, N.J., April 21, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Antimicrobial Therapy Inc., publisher and developer of The Sanford Guide, today announced a collaboration to make Sanford Guide easily accessible from within DoseMeRx™, TRHC’s precision dosing solution.The agreement includes the addition of links to Sanford Guide’s clinically relevant anti-infective drug information and guidelines for the treatment of infectious diseases. Sanford Guide Web Edition and Sanford Guide All Access customers can now seamlessly access their subscription-based resources directly from within DoseMeRx, reducing the time needed to evaluate treatment considerations.“Sanford Guide’s mission is to provide clinically actionable...

VANCOUVER, British Columbia, April 21, 2020 (GLOBE NEWSWIRE) — Global Care Capital Corp. (CSE: HLTH, OTC: RSCZF, FRANKFURT: L6V1) (the “Company” or “Global Care”) is pleased to announce that ViraxClear, has obtained Emergency Use Authorization (EUA) by the Food and Drug Administration (“FDA”) for the COVID-19 test kits it distributes and markets. ViraxClear’s tests can be used by clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA). ViraxClear’s COVID-19 test kit also has CE marking allowing sales to the European Community, and to other global markets that accept a CE marking as valid regulatory approval following routine local product registration. The Company has conducted normal course due diligence to verify the FDA (EUA) and CE marking approvals for the antibody test kits that ViraxClear markets...